|

Dual antiplatelet therapy (DAPT) Clinical Trials

2 actively recruiting trials

▲ +1 trial since May 2026

Top Sponsors

  • Gan Lijun1
  • Fondazione Ricerca e Innovazione Cardiovascolare ETS1

Indications

  • Heart Disease2
  • Clopidogrel1
  • Cyclooxygenase Inhibitors1
  • Single Antiplatelet Therapy1
  • High Bleeding Risk1

Other2 trials

Single vs. Dual Antiplatelet Therapy in Elderly or HBR Patients Undergoing Percutaneous Intervention With DCB (PICCOLETO IV-EPIC 38)
N/A
Single vs. Dual Antiplatelet Therapy in Patients Undergoing Percutaneous Intervention With DCB-only Strategy (KONG-FREEDOM-I)
N/A

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.